Literature DB >> 2511319

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

S M Huson1, D A Compston, P S Harper.   

Abstract

The age of appearance and diagnostic value of the major defining features of von Recklinghausen neurofibromatosis (NF-1) have been studied in 168 cases from 73 families. In assessing children of an affected patient, those who have inherited the gene can be distinguished from their normal sibs on the basis of whether or not café au lait (CAL) spots are present by the age of five years. Lisch nodules appear before cutaneous neurofibromas and are a useful clinical aid in the assessment of unusual cases, those in whom the diagnosis is equivocal, and children with multiple CAL spots but no family history of NF-1. Sixty-nine of the families were identified through a population based study in south east Wales and the frequency of complications in 135 affected subjects from these families has been used to develop figures for genetic counselling. For these purposes, the complications of NF-1 can be usefully divided into four categories: intellectual handicap (33%) (moderate/severe retardation 3.2%, minimal retardation/learning difficulties 29.8%); complications developing in childhood and causing lifelong morbidity (8.5%); 'treatable' complications which can develop at any age (15.7%); and malignant or CNS tumours (4.4 to 5.2%).

Entities:  

Mesh:

Year:  1989        PMID: 2511319      PMCID: PMC1015741          DOI: 10.1136/jmg.26.11.712

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

Authors:  J C Carey; J M Laub; B D Hall
Journal:  Birth Defects Orig Artic Ser       Date:  1979

2.  Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results.

Authors:  I M Modlin; J R Farndon; A Shepherd; I D Johnston; T L Kennedy; D A Montgomery; R B Welbourn
Journal:  Br J Surg       Date:  1979-07       Impact factor: 6.939

3.  Pulsating enophthalmos and choroidal hamartomas: two rare stigmata of neurofibromatosis.

Authors:  P J Savino; J S Glaser; M N Luxenberg
Journal:  Br J Ophthalmol       Date:  1977-07       Impact factor: 4.638

4.  Von Recklinghausen's disease: a clinicopathological study.

Authors:  R D Brasfield; T K Das Gupta
Journal:  Ann Surg       Date:  1972-01       Impact factor: 12.969

5.  Congenital pseudarthrosis of the tibia.

Authors:  R T Morrissy; E J Riseborough; J E Hall
Journal:  J Bone Joint Surg Br       Date:  1981

6.  Malignancy in neurofibromatosis.

Authors:  D G Hope; J J Mulvihill
Journal:  Adv Neurol       Date:  1981

7.  Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis; contribution to elucidation of interrelationship and eugenics of the syndromes.

Authors:  A BORBERG
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1951

8.  Café-au-lait spots in schoolchildren.

Authors:  R G Burwell; N J James; D I Johnston
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

9.  Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

Authors:  R A Lewis; V M Riccardi
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

10.  Brief clinical report: aqueductal stenosis leading to hydrocephalus--an unusual manifestation of neurofibromatosis.

Authors:  A Horwich; V M Riccardi; U Francke
Journal:  Am J Med Genet       Date:  1983-03
View more
  39 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

2.  Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.

Authors:  Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; David Janhofer; Eva Dombi; Richard S Dunn; Mi-Ok Kim; Andrea R Masters; David R Jones; Timothy P Cripe; Nancy Ratner
Journal:  Pediatr Blood Cancer       Date:  2015-04-22       Impact factor: 3.167

3.  Unequal meiotic crossover: a frequent cause of NF1 microdeletions.

Authors:  C López Correa; H Brems; C Lázaro; P Marynen; E Legius
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

4.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Authors:  S M Huson; D A Compston; P Clark; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

5.  A clinical study of type 1 neurofibromatosis in north west England.

Authors:  J M McGaughran; D I Harris; D Donnai; D Teare; R MacLeod; R Westerbeek; H Kingston; M Super; R Harris; D G Evans
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

6.  Genetic Counseling, Reproductive Behavior and Future Reproductive Intentions of People with Neurofibromatosis Type 1 (NF1).

Authors:  M Ponder; F Murton; N Hallowell; H Statham; J Green; M Richards
Journal:  J Genet Couns       Date:  1998-08       Impact factor: 2.537

7.  Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.

Authors:  Lennart Well; Johannes Salamon; Michael G Kaul; Said Farschtschi; Jochen Herrmann; Karin I Geier; Christian Hagel; Maximilian Bockhorn; Peter Bannas; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

8.  Population-specific differences in gene conversion patterns between human SUZ12 and SUZ12P are indicative of the dynamic nature of interparalog gene conversion.

Authors:  Tanja Mussotter; Kathrin Bengesser; Josef Högel; David N Cooper; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2014-01-03       Impact factor: 4.132

9.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 10.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.